UPDATE : Monday, September 7, 2020
상단여백
FDA approves Pfizer’s Remicade biosimilar
Pfizer said Wednesday that it received U.S. Food and Drug Administration’s ...
by Lee Han-soo  |  2017-12-14 17:16
라인
Samsung BioLogics’ 2nd factory gets European approval
Samsung BioLogics said Thursday that its second factory received manufactur...
by Lee Han-soo  |  2017-12-14 10:52
라인
‘Surge of gene-therapy providing hospitals to benefit Invossa’
With hospitals increasingly registering as a provider of gene therapies, Ko...
by Nam Doo-hyun  |  2017-12-12 15:59
라인
PCL shares rise despite regulator’s warning
Shares of PCL, a provider of in vitro diagnostic products, have risen again...
by Nam Doo-hyun  |  2017-12-12 11:02
라인
Oscotec shares rebound on launch of US clinical trial
Shares of Oscotec rebounded on Monday on the company’s announcement that it...
by Nam Doo-hyun  |  2017-12-11 15:50
라인
ToolGen’s shares jump on gene therapy market expectations
With rising expectations for a rapid growth of gene therapy market, investo...
by Nam Doo-hyun  |  2017-12-11 15:16
라인
MGmed to run world’s 1st postmortem DNA bank
MGmed, a Korean firm specializing in molecular diagnostic techniques for ge...
by Marian Chu  |  2017-12-08 17:11
라인
Toolgen wins German utility model for gene editing tool
Toolgen said Friday that it has completed the registration of two German ut...
by Lee Han-soo  |  2017-12-08 16:56
라인
Celltrion seeks to shift to main bourse
Biosimilar maker Celltrion is aiming to relist its stocks on the Korea Exch...
by Lee Han-soo  |  2017-12-07 11:25
라인
Medipost wins patent for Cartistem in Europe
Medipost said Wednesday that it has acquired patents on its core production...
by Lee Han-soo  |  2017-12-06 13:15
라인
MGmed emerges as largest shareholder of UK bio venture
MGmed said it has emerged as the largest stakeholder of Oxford Vacmedix (OV...
by Marian Chu  |  2017-12-06 13:00
라인
Kolon Life Science confident to make Invossa global blockbuster
Despite proved efficacy in reducing pain for osteoarthritis patients, Kolon...
by Nam Doo-hyun  |  2017-12-06 09:30
라인
ViroMed starts trial on VM202’s effect on peripheral artery disease
VM BioPharma, the U.S subsidiary of ViroMed, announced Tuesday that it has ...
by Lee Han-soo  |  2017-12-05 15:40
라인
Shares of biotech firms, listed with ‘exceptional techs,’ rise above offer price
Most of the biotechnology companies, listed on Kosdaq early this year under...
by Nam Doo-hyun  |  2017-12-05 14:38
라인
Sewon seeks p3 clinical trials for cartilage cell therapy in Japan
Sewon Cellontech said Monday that Olympus RMS has submitted phase 3 clinica...
by Lee Han-soo  |  2017-12-04 16:17
라인
Cord blood biotech firms enjoy stock price gains this year
Korean biotech firms with major pipelines in cord blood banks and umbilical...
by Nam Doo-hyun  |  2017-12-04 15:02
라인
Nature Cell’s clinical trial on Alzheimer therapy running smoothly
Nature Cell said Monday that it has injected 10 doses of Astrostem, a stem-...
by Lee Han-soo  |  2017-12-04 14:57
라인
FDA approves clinical trial for Pharmicell’s liver cirrhosis treatment
Pharmicell said Monday that the U.S. Food and Drug Administration has appro...
by Lee Han-soo  |  2017-12-04 14:57
라인
Tego Science shares surge on robust earnings
The surging of Tego Science shares on Kosdaq on Thursday drew attention, pr...
by Nam Doo-hyun  |  2017-12-01 11:48
라인
Panagene wins patent for molecular diagnostic platform
Panagene said Thursday that it has completed its patent registration for PA...
by Lee Han-soo  |  2017-12-01 11:02
-이전212223242526-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top